Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-24-031482
Filing Date
2024-10-17
Accepted
2024-10-17 16:32:05
Documents
5
Period of Report
2024-12-10

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A rvph20241014_pre14a.htm PRE 14A 476812
2 capn.jpg GRAPHIC 38729
3 card01.jpg GRAPHIC 354835
4 card02.jpg GRAPHIC 158619
5 comp.jpg GRAPHIC 39283
  Complete submission text file 0001437749-24-031482.txt   1292919
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38634 | Film No.: 241377982
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)